BUY Cipla Ltd. — Siddharth Rai Mangala
bySiddharth Rai MangalaHorizon: NA (inferred Intraday)30 Oct 2026, 10:22 am ISTvia Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Cipla Q2 Results Review: ICICI Securities Remains Bullish After Inline Numbers; Check Target Price
NewsNdtv-Profit·28 Oct · 2d ago
Cipla’s US recovery, biosimilar pipeline key to future growth prospects
NewsEt-Markets·28 Oct · 2d ago
Dr Reddy's stock could rise 10-15% if a major biosimilar gets approved in December: Systematix
NewsCnbc-Tv18·27 Oct · 3d ago
Cipla Q2 Results: US sales meet expectations, margins narrow from last year
NewsCnbc-Tv18·27 Oct · 3d ago
Cipla reported unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
NSE · Outcome of Board Meeting·27 Oct · 3d ago
Cipla Eyes Margin Rebound From FY28 As Middle East Freight Squeeze Hits Q2 Costs
NewsNdtv-Profit·27 Oct · 2d ago
Cipla Q2 net profit falls 35% to Rs 878 crore, revenue dips 2%
NewsEt-Markets·27 Oct · 2d ago
Cipla Q2 Results: Profit falls 35% YoY to Rs 878 crore; revenue slips 2%
NewsEt-Markets·27 Oct · 3d ago
Cipla reported Q2FY27 consolidated financial results with revenue of INR 7,404 Cr and PAT of INR 878 Cr, showing a decline in profitability compared to the same quarter last year.
BSE · Company Update·27 Oct · 3d ago
Cipla Q2 Preview: Net Profit Seen Falling 29% As US Business Faces Headwinds
NewsNdtv-Profit·26 Oct · 3d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cipla
- BUY — Elara Capital28 Oct 2026 · ~1 year · target ₹1,455 · Active
- SELL — Morgan Stanley28 Oct 2026 · ~1 year · target ₹1,214 · Active
- BUY — IDBI Capital26 Oct 2026 · ~2 weeks · target ₹1,403 · SL hit
- BUY — Prakash Gaba26 Oct 2026 · Same day · target ₹1,350 · Target hit
- BUY — Manas Jaiswal26 Oct 2026 · Same day · target ₹1,360 · Expired
More from Siddharth Rai Mangala
- BUY Grasim Industries30 Oct 2026 · Same day · target ₹3,020 · Expired
- BUY WESTLIFE FOODWORLD30 Oct 2026 · ~2 weeks · target ₹750 · Active
- BUY Zydus Lifesciences30 Oct 2026 · Same day · target ₹1,230 · Target hit
- BUY Lemon Tree Hotels30 Oct 2026 · ~2 weeks · target ₹117 · Active
- BUY RBL Bank29 Oct 2026 · ~2 weeks · target ₹380 · Active

